organization WH (2021) Suicide.https://www.who.int/news-room/fact-sheets/detail/ suicide

Miola A, Dal Porto V, Tadmor T et al (2021) Increased c-reactive protein concentration and suicidal behavior in people with psychiatric disorders: a systematic review and meta-analysis. Acta Psychiatr Scand 144:537–552. https://doi.org/10.1111/acps.13351

Article  PubMed  PubMed Central  CAS  Google Scholar 

Su MH, Chen HC, Lu ML et al (2018) Risk profiles of personality traits for suicidality among mood disorder patients and community controls. Acta Psychiatr Scand 137:30–38. https://doi.org/10.1111/acps.12834

Article  PubMed  Google Scholar 

Li X, Mu F, Liu D et al (2022) Predictors of suicidal ideation, suicide attempt and suicide death among people with major depressive disorder: a systematic review and meta-analysis of cohort studies. J Affect Disord 302:332–351. https://doi.org/10.1016/j.jad.2022.01.103

Article  PubMed  Google Scholar 

Paljärvi T, Tiihonen J, Lähteenvuo M et al (2023) Psychotic depression and deaths due to suicide. J Affect Disord 321:28–32. https://doi.org/10.1016/j.jad.2022.10.035

Article  PubMed  Google Scholar 

Gordovez FJA, McMahon FJ (2020) The genetics of bipolar disorder. Mol Psychiatry 25:544–559. https://doi.org/10.1038/s41380-019-0634-7

Article  PubMed  Google Scholar 

Plans L, Barrot C, Nieto E et al (2019) Association between completed suicide and bipolar disorder: a systematic review of the literature. J Affect Disord 242:111–122. https://doi.org/10.1016/j.jad.2018.08.054

Article  PubMed  CAS  Google Scholar 

Edinoff AN, Akuly HA, Hanna TA et al (2021) Selective serotonin reuptake inhibitors and adverse effects: a narrative review. Neurol Int 13:387–401. https://doi.org/10.3390/neurolint13030038

Article  PubMed  PubMed Central  CAS  Google Scholar 

Möller HJ, Baldwin DS, Goodwin G et al (2008) Do ssris or antidepressants in general increase suicidality? Wpa section on pharmacopsychiatry: Consensus statement. Eur Arch Psychiatry Clin Neurosci 258 Suppl 3:3–23. https://doi.org/10.1007/s00406-008-3002-1

Article  Google Scholar 

Gunnell D, Ashby D (2004) Antidepressants and suicide: what is the balance of benefit and harm. BMJ 329:34–38. https://doi.org/10.1136/bmj.329.7456.34

Article  PubMed  PubMed Central  CAS  Google Scholar 

Pompili M, Serafini G, Innamorati M et al (2010) Antidepressants and suicide risk: a comprehensive overview. Pharmaceuticals (Basel) 3:2861–2883. https://doi.org/10.3390/ph3092861

Article  PubMed  Google Scholar 

Rönnqvist I, Nilsson FK, Nordenskjöld A (2021) Electroconvulsive therapy and the risk of suicide in hospitalized patients with major depressive disorder. JAMA Netw Open 4:e2116589. https://doi.org/10.1001/jamanetworkopen.2021.16589

Article  PubMed  PubMed Central  Google Scholar 

Luccarelli J, Humphrey D, McCoy TH Jr et al (2023) Changes in self-reported suicidal ideation during treatment with electroconvulsive therapy: a retrospective cohort study. Acta Psychiatr Scand 148:553–560. https://doi.org/10.1111/acps.13603

Article  PubMed  Google Scholar 

Mann JJ, Apter A, Bertolote J et al (2005) Suicide prevention strategies: a systematic review. JAMA 294:2064–2074. https://doi.org/10.1001/jama.294.16.2064

Article  PubMed  CAS  Google Scholar 

Zalsman G, Hawton K, Wasserman D et al (2016) Suicide prevention strategies revisited: 10-year systematic review. Lancet Psychiatry 3:646–659. https://doi.org/10.1016/s2215-0366(16)30030-x

Article  PubMed  Google Scholar 

Andrade C (2019) Oral ketamine for depression, 1: pharmacologic considerations and clinical evidence. J Clin Psychiatry 80. https://doi.org/10.4088/JCP.19f12820

Daly EJ, Singh JB, Fedgchin M et al (2018) Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression: a randomized clinical trial. JAMA Psychiatry 75:139–148. https://doi.org/10.1001/jamapsychiatry.2017.3739

Article  PubMed  Google Scholar 

Wilkinson ST, Ballard ED, Bloch MH et al (2018) The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis. Am J Psychiatry 175:150–158. https://doi.org/10.1176/appi.ajp.2017.17040472

Article  PubMed  Google Scholar 

Williams NR, Heifets BD, Bentzley BS et al (2019) Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism. Mol Psychiatry 24:1779–1786. https://doi.org/10.1038/s41380-019-0503-4

Article  PubMed  CAS  Google Scholar 

Zanos P, Moaddel R, Morris PJ et al (2016) Nmdar inhibition-independent antidepressant actions of ketamine metabolites. Nature 533:481–486. https://doi.org/10.1038/nature17998

Article  PubMed  PubMed Central  CAS  Google Scholar 

Canady VA (2020) Fda approves esketamine treatment for mdd, suicidal ideation. 30:6–7. https://doi.org/10.1002/mhw.32471

Witt K, Potts J, Hubers A et al (2020) Ketamine for suicidal ideation in adults with psychiatric disorders: a systematic review and meta-analysis of treatment trials. Aust N Z J Psychiatry 54:29–45. https://doi.org/10.1177/0004867419883341

Article  PubMed  Google Scholar 

Ionescu DF, Swee MB, Pavone KJ et al (2016) Rapid and sustained reductions in current suicidal ideation following repeated doses of intravenous ketamine: secondary analysis of an open-label study. J Clin Psychiatry 77:e719–725. https://doi.org/10.4088/JCP.15m10056

Article  PubMed  Google Scholar 

Phillips JL, Norris S, Talbot J et al (2020) Single and repeated ketamine infusions for reduction of suicidal ideation in treatment-resistant depression. Neuropsychopharmacology 45:606–612. https://doi.org/10.1038/s41386-019-0570-x

Article  PubMed  CAS  Google Scholar 

Sanacora G, Frye MA, McDonald W et al (2017) A consensus statement on the use of ketamine in the treatment of mood disorders. JAMA Psychiatry 74:399–405. https://doi.org/10.1001/jamapsychiatry.2017.0080

Article  PubMed  Google Scholar 

Xiong J, Lipsitz O, Chen-Li D et al (2021) The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: a systematic review and meta-analysis. J Psychiatr Res 134:57–68. https://doi.org/10.1016/j.jpsychires.2020.12.038

Article  PubMed  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM et al (2021) The prisma 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71

Article  PubMed  PubMed Central  Google Scholar 

Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382–389. https://doi.org/10.1192/bjp.134.4.382

Article  PubMed  CAS  Google Scholar 

Horon R, McManus T, Schmollinger J et al (2013) A study of the use and interpretation of standardized suicide risk assessment: measures within a psychiatrically hospitalized correctional population. Suicide Life Threat Behav 43:17–38. https://doi.org/10.1111/j.1943-278X.2012.00124.x

Article  PubMed  Google Scholar 

Posner K, Brown GK, Stanley B et al (2011) The columbia-suicide severity rating scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry 168:1266–1277. https://doi.org/10.1176/appi.ajp.2011.10111704

Article  PubMed  PubMed Central  Google Scholar 

Sterne JAC, Savović J, Page MJ et al (2019) Rob 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898. https://doi.org/10.1136/bmj.l4898

Article  PubMed  Google Scholar 

Higgins J, S G (2011) Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated march 2011]. The Cochrane Collaboration https://handbook-5-1.cochrane.org/

Higgins JP, Thompson SG, Deeks JJ et al (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560. https://doi.org/10.1136/bmj.327.7414.557

Article